we should be in a trading halt imo

Information has come to light that casts doubt on the strength of our patent position in China. The US Allele patents are probably immaterial, but still cast further doubt on the supposed broad nature of our patent position there as well.

BLT's HBV program is based in China. This is price sensitive.

Buyers are beginning to disappear and I don't blame them. I would not be buying on this uncertainty.

Were is Peter French. We need clarification soon before this thing falls back to all time lows.